NCT05194735 2025-11-10
Phase I/II Study of Autologous T Cells to Express T-Cell Receptors (TCRs) in Subjects With Solid Tumors
Alaunos Therapeutics
Phase 1/2 Terminated
Alaunos Therapeutics
Affimed GmbH
Gilead Sciences
Clinigen, Inc.
United Therapeutics